Anavex Life Sciences Corp (AVXL)
9.02
+0.54
(+6.43%)
USD |
NASDAQ |
Nov 21, 16:00
9.035
+0.02
(+0.17%)
After-Hours: 20:00
Anavex Life Sciences Shares Outstanding: 84.80M for Aug. 6, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
August 06, 2024 | 84.80M |
June 30, 2024 | 84.80M |
May 09, 2024 | 84.64M |
April 26, 2024 | 84.64M |
March 31, 2024 | 83.62M |
February 07, 2024 | 82.11M |
December 31, 2023 | 82.09M |
November 24, 2023 | 82.09M |
September 30, 2023 | 82.07M |
August 08, 2023 | 81.95M |
June 30, 2023 | 81.39M |
May 08, 2023 | 80.84M |
March 31, 2023 | 80.24M |
March 27, 2023 | 79.61M |
February 07, 2023 | 78.03M |
February 03, 2023 | 78.03M |
January 27, 2023 | 78.03M |
December 31, 2022 | 78.03M |
November 28, 2022 | 77.96M |
September 30, 2022 | 77.94M |
August 09, 2022 | 77.94M |
June 30, 2022 | 77.94M |
May 10, 2022 | 77.41M |
March 31, 2022 | 77.16M |
March 28, 2022 | 76.92M |
Date | Value |
---|---|
February 08, 2022 | 76.17M |
December 31, 2021 | 76.16M |
November 19, 2021 | 76.02M |
September 30, 2021 | 75.92M |
August 12, 2021 | 75.71M |
June 30, 2021 | 75.71M |
June 24, 2021 | 72.42M |
May 11, 2021 | 70.04M |
March 31, 2021 | 70.03M |
March 29, 2021 | 70.03M |
February 12, 2021 | 69.49M |
December 31, 2020 | 66.96M |
December 28, 2020 | 66.96M |
September 30, 2020 | 62.05M |
August 04, 2020 | 60.19M |
June 30, 2020 | 60.08M |
May 07, 2020 | 58.66M |
April 27, 2020 | 58.66M |
March 31, 2020 | 58.66M |
February 19, 2020 | 58.66M |
February 11, 2020 | 58.66M |
February 06, 2020 | 58.66M |
December 31, 2019 | 57.08M |
December 12, 2019 | 56.12M |
September 30, 2019 | 52.65M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
56.12M
Minimum
Dec 12 2019
84.80M
Maximum
Jun 30 2024
73.46M
Average
76.92M
Median
Mar 28 2022
Shares Outstanding Benchmarks
NovaBay Pharmaceuticals Inc | 4.886M |
Palatin Technologies Inc | 19.55M |
iBio Inc | 9.150M |
Theriva Biologics Inc | 2.782M |
Oragenics Inc | 12.21M |